- Home
- LFST vs RXRX Comparison
LFST vs RXRX Comparison
Compare LFST & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFST
- RXRX
- Stock Information
- Founded
- LFST 2015
- RXRX 2013
- Country
- LFST United States
- RXRX United States
- Employees
- LFST N/A
- RXRX N/A
- Industry
- LFST Medical/Nursing Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- LFST Health Care
- RXRX Health Care
- Exchange
- LFST Nasdaq
- RXRX Nasdaq
- Market Cap
- LFST 3.0B
- RXRX 2.6B
- IPO Year
- LFST 2021
- RXRX 2021
- Fundamental
- Price
- LFST $6.70
- RXRX $5.81
- Analyst Decision
- LFST Buy
- RXRX Buy
- Analyst Count
- LFST 4
- RXRX 4
- Target Price
- LFST $8.63
- RXRX $8.25
- AVG Volume (30 Days)
- LFST 2.3M
- RXRX 18.0M
- Earning Date
- LFST 05-08-2025
- RXRX 05-08-2025
- Dividend Yield
- LFST N/A
- RXRX N/A
- EPS Growth
- LFST N/A
- RXRX N/A
- EPS
- LFST N/A
- RXRX N/A
- Revenue
- LFST $1,250,970,000.00
- RXRX $58,839,000.00
- Revenue This Year
- LFST $15.35
- RXRX $64.84
- Revenue Next Year
- LFST $13.86
- RXRX $55.98
- P/E Ratio
- LFST N/A
- RXRX N/A
- Revenue Growth
- LFST 18.50
- RXRX 32.00
- 52 Week Low
- LFST $4.64
- RXRX $5.60
- 52 Week High
- LFST $8.61
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- LFST 34.56
- RXRX 37.70
- Support Level
- LFST $6.52
- RXRX $6.27
- Resistance Level
- LFST $7.08
- RXRX $6.94
- Average True Range (ATR)
- LFST 0.24
- RXRX 0.39
- MACD
- LFST -0.01
- RXRX -0.02
- Stochastic Oscillator
- LFST 27.48
- RXRX 6.61
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.